Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - PACER: T2 Motion to Extend the Fact Discovery Cutoff 3-1-13

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

BaNosser

Rank: President [?]

Points: 24217 [?]

Votes: 157 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

PACER: T2 Motion to Extend the Fact Discovery Cutoff 3-1-13

posted on Mar 02, 2013 12:47AM

Motion to Extend the Fact Discovery Cutoff 3-1-13

http://photos.imageevent.com/banos/t3/Motion%20to%20Extend%20the%20Fact%20Discovery%20Cutoff%203-1-13.pdf

5 Recommendations

Re: PACER: T2 Motion to Extend the Fact Discovery Cutoff 3-1-13

HUNTINGTON-L

Mar 02, 2013 11:09AM

Re: PACER: T2 Motion to Extend the Fact Discovery Cutoff 3-1-13

HUNTINGTON-L

Mar 02, 2013 11:09AM

Re: PACER: T2 Motion to Extend the Fact Discovery Cutoff 3-1-13

HUNTINGTON-L

Mar 02, 2013 11:10AM

Re: PACER: T2 Motion to Extend the Fact Discovery Cutoff 3-1-13

HUNTINGTON-L

Mar 02, 2013 11:10AM

Sorry

HUNTINGTON-L

Mar 02, 2013 11:46AM

Reply New Message

Back To Forum List View

Please to post a reply